Skip to main content

SEER-CV Registry (EFFECTIVENESS OF PCSK9I IN THE PREVENTION OF CARDIOVASCULAR DISEASE: A GLOBAL REGISTRY REAL WORLD DATA IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE)

Clinical Trial Grant
Duke Scholars

Awarded By

Amgen, Inc.

Start Date

September 1, 2021

End Date

July 1, 2026
 

Awarded By

Amgen, Inc.

Start Date

September 1, 2021

End Date

July 1, 2026